This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Best Value Stocks to Buy for March 15th
by Zacks Equity Research
BSVN, RRBI and NRIM made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 15, 2024.
Best Value Stocks to Buy for March 5th
by Zacks Equity Research
GM, INSW and BSVN made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 5, 2023.
Best Income Stocks to Buy for March 5th
by Zacks Equity Research
SBSI, EMBT and BSVN made it to the Zacks Rank #1 (Strong Buy) income stocks list on March 5, 2023.
Should Value Investors Buy Bank7 (BSVN) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Hancock Whitney's (HWC) Loan, Rates Aid Amid Weak Asset Quality
by Zacks Equity Research
Hancock Whitney (HWC) gets support from solid loan balance, high interest rates and efforts to improve fee income. Yet, weakness in the mortgage banking business and poor asset quality are headwinds.
Does Bank7 (BSVN) Have the Potential to Rally 28.57% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 28.6% in Bank7 (BSVN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Hilltop Holdings (HTH) Rides on High Rates, Asset Quality Weak
by Zacks Equity Research
Hilltop Holdings' (HTH) strengthened balance sheet and high rates to aid financials amid weak asset quality and mortgage origination concerns.
Here's Why Hancock Whitney (HWC) is Worth Buying Right Now
by Zacks Equity Research
Hancock Whitney's (HWC) strong balance sheet and revenue growth strategy are likely to support its financials. This makes the stock worth betting on right now.
Earnings Estimates Moving Higher for Bank7 (BSVN): Time to Buy?
by Zacks Equity Research
Bank7 (BSVN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts Predict a 26.4% Upside in Bank7 (BSVN): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 26.4% upside potential for Bank7 (BSVN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Best Income Stocks to Buy for February 1st
by Zacks Equity Research
MSBI, BSVN and CINF made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 1, 2023.
Best Value Stocks to Buy for February 1st
by Zacks Equity Research
NRG, BSVN and MSBI made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 1, 2023.
Bank7 (BSVN) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Bank7 (BSVN) delivered earnings and revenue surprises of 250% and 33.01%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Bears are Losing Control Over Bank7 (BSVN), Here's Why It's a 'Buy' Now
by Zacks Equity Research
Bank7 (BSVN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Hilltop Holdings (HTH) Beats Q4 Earnings Estimates
by Zacks Equity Research
Hilltop Holdings (HTH) delivered earnings and revenue surprises of 10% and 1.78%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Should Value Investors Buy Bank7 (BSVN) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Bank7 (BSVN) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Bank7 (BSVN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Are Investors Undervaluing Bank7 (BSVN) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Bank7 (BSVN) Lags Q3 Earnings Estimates
by Zacks Equity Research
Bank7 (BSVN) delivered earnings and revenue surprises of -17.48% and 2.61%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
WesBanco (WSBC) Misses Q3 Earnings Estimates
by Zacks Equity Research
WesBanco (WSBC) delivered earnings and revenue surprises of -4.84% and 0.34%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Is Bank7 (BSVN) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
U.S. Bancorp (USB) Rides on Revenue Growth Amid High Costs
by Zacks Equity Research
A rise in revenues, solid loan and deposit balance and strategic expansion activities are likely to support U.S. Bancorp (USB). However, escalated expenses and lack of diversification in the loan portfolio are concerns.
Rise in NII & High Rates Aid Comerica (CMA), High Costs Hurt
by Zacks Equity Research
Decent loan growth, rising NII, adequate liquidity and sustainable capital distributions are major tailwinds for Comerica (CMA). However, rising costs are likely to limit bottom-line growth.
Is Bank7 (BSVN) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Regions Financial (RF) Aided by NII & Loan Growth Amid Cost Woes
by Zacks Equity Research
A rise in net interest income and solid balance sheet bode well for Regions Financial (RF). However, a lack of diversification in the loan portfolio and elevated costs are concerns.